Clinical Trials Browser

OTHER × Metastatic Urothelial Cancer × pembrolizumab × Clear all

NCT02826564 2024-07-17

Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer

Phase 1 Completed

Metastatic Urothelial Cancer